New Delhi: Claris Lifesciences on Monday announced the delisting of Equity shares from the BSE with effect from March 22, 2018, while the discontinuation of trading of equity shares will be from March 15, 2018.
The delisting of the equity shares from the stoke exchange had been applied on February 26, 2018 by the company.
The move comes after the company received a letter in December 2017, from the promoter Athanas Enterprise Pvt Ltd to consider delisting of shares of the pharma company from the stock exchange.
The company said in an statement, “Pursuant to the final delisting approval, the ‘permitted to trade’ status given to the equity shares by the Metropolitan Stock Exchange of India shall also stand withdrawn on and from the date of discontinuation of trading.”
Below is the attachment for the same.